Brief: Moberg Pharma And Cipher Pharmaceuticals Sign Exclusive License Agreement For Mob-015 In Canada

Moberg Pharma AB (publ)

18/09/2018 07:34

Sept 18 (Reuters) - Moberg Pharma Ab (Publ)  MBPH.ST :
    * MOBERG PHARMA AND CIPHER PHARMACEUTICALS SIGN EXCLUSIVE
LICENSE
AGREEMENT FOR MOB-015 IN CANADA
    * SAYS UNDER AGREEMENT, MOBERG PHARMA IS ELIGIBLE TO RECEIVE
USD
14.6 MILLION IN ONE-TIME PAYMENTS AND MILESTONES, AS WELL AS
ROYALTIES ON NET SALES IN CANADA

Source text for Eikon:  ID:nWkr368F53 
Further company coverage:  MBPH.ST 

 (Reporting by Stockholm Newsroom)
 ((stockholm.newsroom@thomsonreuters.com; +4687001017;))